® Publicaciones Científicas


  • Inhibition of fibrinolysis by a synthetic urokinase inhibitor enhances lung colonization of metastatic murine mammary tumor cells. D.F. Alonso, G.E. Bertolesi, E.F. Farías, D.E. Gomez, E. Bal de Kier Joffé. Oncology Reports, 3: 1055-1058, 1996.
  • Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells. D.F. Alonso, G. Skilton, H.G. Farina, M.S. De Lorenzo, D.E. Gomez. International Journal of Oncology, 10: 375-379, 1997.
  • Atypical cilia in testicular cells from normal rats. R. Ponzio, D.F. Alonso, D.E. Gomez. Journal of Submicroscopic Cytology and Pathology, 29: 313-316, 1997.
  • Tissue inhibitors of metalloproteinases; structure, regulation and biological functions. D.E. Gomez, D.F. Alonso, H. Yoshiji, U.P. Thorgeirsson. European Journal of Cell Biology, 74: 111-122, 1997.
  • Antisense oligonucleotides strategies in cancer. D.E. Gomez, D.F. Alonso, A.M. Irribarren. South-American Journal of Cancer, 1: 180-190, 1997.
  • Insight into the profibrinolytic activity of heparin: effects on the activation of plasminogen mediated by urokinase. G.E. Bertolesi, E.F. Farías, D.F. Alonso, E. Bal de Kier Joffé, L. Lauría de Cidre, A.M. Eiján. Blood Coagulation and Fibrinolysis, 8: 403-410, 1997.
  •  Fibrin formation induced by tumor procoagulants enhances urokinase activity produced by mammary carcinoma cells. D.F. Alonso, M.S. De Lorenzo, A.M. Tejera, D.E. Gomez. Oncology Reports, 5: 209-212, 1998.
  • Irreversible telomere shortening by 3’-azido2’,3’-dideoxythymidine (AZT) treatment. D.E. Gomez, A.M. Tejera, O.A. Olivero. Biochemical and Biophysical Research Communications, 246: 107-110, 1998.
  • Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of mevalonate pathway of cholesterol synthesis. D.F. Alonso, H.G. Farina, G. Skilton, M.R. Gabri, M.S. De Lorenzo, D.E. Gomez. Breast Cancer Research and Treatment, 50: 83-93, 1998.
  • Histopathological findings in a highly invasive mouse mammary carcinoma transfected with human tisssue inhibitor of metalloproteinases-1. D.F. Alonso, G. Skilton, M.S. De Lorenzo, A.M. Scursoni, H. Yoshiji and D.E. Gomez. Oncology Reports, 5:1083-1087, 1998.
  • Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428. D.F. Alonso, A.M. Tejera, E.F. Farías, E. Bal de Kier Joffé, D.E. Gomez. Anticancer Research, 18: 4499-4504, 1998.